Treatment of prolactin producing pituitary adenomas.

R. Randall

Abstract:It is now generally agreed that prolactin producing pituitary adenomas (prolactinomas) comprise the largest category of pituitary tumors. As a representative example, in our series of 860 patients with pituitary adenomas treated with transsphenoidal operation between 1972 and 1981, 335 (39%) were prolactin producing and occurred six times more frequently in females than in males. This is particularly interesting because the first successful radioimmunoassay using human prolactin antibodies was reported only ten years ago (1), and human prolactin was not purified until a year later by Hwang, Guida, and Friesen (2), although a sensitive biologic assay using cultures of pregnant mouse breasts was reported in 1969 by Kleinberg and Frantz (3). Prolactinomas, in addition to causing the usual symptoms of an expanding pituitary adenoma such as visual field defects, impairment of pituitary function, headaches, etc., can also lead to endocrine dysfunction secondary to the hyperprolactinemia. It has been estimated that approximately 20% of amenorrheic women have hyperprolactinemia, and our experience (4) would suggest that approximently 5% of women with hyperprolactinemia and amenorrhea from a surgically proven prolactinoma have primary amenorrhea. Hyperprolactinemia in either sex can inhibit the function of the gonads and lead to infertility. It may also cause galactorrhea, which is more frequent in females than in males. Hyperprolactinemia in females can lead to the various endocrine effects listed in Table 1, although some patients with hyperprolactinemia may have no discernible endocrine changes. In a recent analysis of 100 patients we found that 87% of 84 females with prolactinoma and hyperprolactinemia had galactorrhea (5). All 84 females had some menstrual abnormality, the most common being secondary amenorrhea. However, some patients with hyperprolactinemia have regular menses which are either ovulatory or anovulatory, whereas others have irregular menses which also may be ovulatory or anovulatory. When primary amenorrhea occurs it may accompany delayed puberty if the hyperprolactinemia causes hypogonadism before completion of puberty. If the pituitary adenoma is large enough to impair the secretion of growth hormone it can result in somatic retardation in either sex. Analogous findings may be associated with hyperprolactinemia in